Jason Gardner

Jason Gardner is a prominent figure in the biotechnology sector, known for his role as the CEO, President, and Co-founder of Magenta Therapeutics, where he served from November 2016 until February 2023. Under his leadership, Magenta Therapeutics focused on advancing stem cell science to improve transplantation methods for patients with immune and blood-related diseases. The company aimed to create innovative therapies that could effectively reboot blood and immune systems, benefiting patients significantly.1

Prior to his tenure at Magenta, Gardner had a substantial career in various leadership roles within the biotechnology and pharmaceutical industries. He was involved with GSK (GlaxoSmithKline) in multiple capacities, including Vice President roles that centered on drug discovery and regenerative medicine. His experience also includes founding and managing several biotech ventures, showcasing his entrepreneurial spirit and expertise in the field.1

Gardner's educational background and professional experiences have positioned him as a leader in transforming medical practices through innovative biotech solutions. He is now the CEO of Ampersand Biomedicines, continuing his commitment to advancing healthcare.1